Contact
Please use this form to send email to PR contact of this press release:
ROSEN, LEADING INVESTOR COUNSEL, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in Securities Class Action; Encourages Investors with Losses Exceeding $100K to Contact Firm – IPHA
TO: